However, ongoing vigilance is necessary to understand fully the nuanced effects of DPP-4 inhibitors on heart failure, making EXAMINE a critical foundation for future research and clinical decision-making in the management of type 2 diabetes and cardiovascular risk. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.